NUREXONE BIOLOGIC INC.

Highlights NurExone Biologic Inc.

Equities

NRX

CA67059R1091

Market Closed - Toronto S.E. Other stock markets 15:59:56 2024-06-04 EDT			5-day change	1st Jan Change
0.47 ^CAD	-7.84%		-4.08%	+59.32%

05-29	NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	NurExone Biologic Announces OTCQB Listing And DTC Eligibility	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-29	CI
NurExone Biologic Announces OTCQB Listing And DTC Eligibility	04-25	MT
NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-02	CI
NurExone Biologic Building a Research and Development Facility in Israel	03-08	MT
NurExone Biologic Inc. Establishes Research and Development Facility in Haifa, Israel	03-08	CI
NurExone Biologic Inc. Expands Intellectual Property Portfolio	02-20	CI
NurExone Biologic Inc. Launches Licensing Efforts for ExoTherapy Platform	02-14	CI
NurExone Biologic Provides Operations Update	23-07-20	MT
NurExone Biologic Posts Q1 Net Loss	23-05-24	MT
NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, For Acute Spinal Cord Injuries Treatmenet	23-05-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer